# OnCo record nct06499285 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06499285/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06499285", "NCT06499285" ;
  schema:name "A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular B"@en ;
  schema:alternateName "RENEW"@en ;
  schema:description "A phase 3 trial of Elritercept run by Takeda, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06499285/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06499285> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2025-05-06" ;
  onco:cancers <https://onco.cc/cancers/mds/>, <https://onco.cc/cancers/mds-lower-risk/> ;
  onco:technologies <https://onco.cc/technologies/cytokine-therapy/> ;
  onco:drugs <https://onco.cc/drugs/elritercept/> ;
  onco:companies <https://onco.cc/companies/takeda/> .